Fed. Circ. Was Right To Deny Amgen IP 'Gambit,' Justices Told | McDermott

COVERAGE

Fed. Circ. Was Right To Deny Amgen IP 'Gambit,' Justices Told

March 14, 2022

Read time: 2 min

Partners, Sarah Columbia and William Gaede were featured in this article in Law360.

William Gaede

Partner

Silicon Valley, San Francisco

You may also like